Supplemental Material: Chemotherapy-Induced Peripheral Neuropathy in Metastatic Breast Cancer Patients Initiating Intravenous Paclitaxel/nab-Paclitaxel

Brenna L. Brady, PhD;Lucci,Matthew;Wilson,Kathleen;Kathleen M. Fox, PhD;Wojtynek,Jeffrey;Cooper,Chelsea;Varker,Helen;Chebili,Christina;Igoni Dokubo, MD;

Supplemental Material: Chemotherapy-Induced Peripheral Neuropathy in Metastatic Breast Cancer Patients Initiating Intravenous Paclitaxel/nab-Paclitaxel

December 23, 2020

Brenna L. Brady, PhD, Matthew Lucci, MPH, Kathleen Wilson, MPH, Kathleen M. Fox, PhD, Jeffrey Wojtynek, PharmD, Chelsea Cooper, PharmD, Helen Varker, BS, Christina Larson Chebili, MA, Igoni Dokubo, MD

Evidence-Based Oncology, January 2021, Volume 27, Issue 1

Supplemental materials for article examining the incidence and impact of chemotherapy induced peripheral neuropathy on clinical and economic outcomes in women with metastatic breast cancer initiating intravenous paclitaxel/nab-paclitaxel.